4//SEC Filing
Ultragenyx Pharmaceutical Inc. 4
Accession 0001209191-14-006661
$RARECIK 0001515673operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:30 PM ET
Size
9.8 KB
Accession
0001209191-14-006661
Insider Transaction Report
Form 4
Nadav Eran
Director
Transactions
- Award
Stock Opton (Right to Buy)
2014-01-30+17,500→ 17,500 totalExercise: $21.00Exp: 2024-01-29→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The option shall vest with respect to 1/36th of the shares monthly such that the options shall be fully vested on the third anniversary of the grant date.
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001515673
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 8:30 PM ET
- Size
- 9.8 KB